Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-14

Clinical Trial Update: Ramelteon Tablets 8mg Drug Use Surveillance: Survey on Insomnia Associated With Sleep-onset Difficulty

View source ↗

Summary

A completed drug-use surveillance trial evaluating Ramelteon 8 mg for insomnia with sleep-onset difficulty; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

Sponsor: Takeda | Conditions: Insomnia | Status: COMPLETED | Results posted: 2016-07-14